Cite
HARVARD Citation
Breining, P. et al. (2021). Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety. Basic & clinical pharmacology & toxicology. 128 (2), pp. 204-212. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Breining, P. et al. (2021). Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety. Basic & clinical pharmacology & toxicology. 128 (2), pp. 204-212. [Online].